Muscarinic toxins

Toxicon

Volumn 58, Issue 6-7, 2011, Pages 455-463

  Servent, Denis ^a   Blanchet, Guillaume ^a   Mourier, Gilles ^a   Marquer, Catherine ^a,b   Marcon, Elodie ^a   Fruchart Gaillard, Carole ^a  

^a SERVICE DE CHIMIE BIOORGANIQUE ET DE MARQUAGE   (France)

^b CNRS   (France)

Author keywords

GPCRs; Muscarinic receptors; Muscarinic toxins; Three finger fold toxins

Indexed keywords

COMPLEMENTARY DNA; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC TOXIN; TOXIN; UNCLASSIFIED DRUG; VENOM;

BETA SHEET; BINDING AFFINITY; CALCIUM TRANSPORT; EXON; HIPPOCAMPUS; IC 50; INTRON; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TOXICITY TESTING; TOXIN ANALYSIS; TOXIN STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM; ELAPID VENOMS; ELAPIDAE; MOLECULAR SEQUENCE DATA; RECEPTORS, MUSCARINIC; STRUCTURE-ACTIVITY RELATIONSHIP; TOXINS, BIOLOGICAL;

DENDROASPIS; SERPENTES;

EID: 82555172155     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2011.08.004     Document Type: Review

References (87)

1. Aird S.D. Ophidian envenomation strategies and the role of purines. Toxicon 2002, 40:335-393.
2. Bradley K.N. Muscarinic toxins from the green mamba. Pharmacol. Ther. 2000, 85:87-109.
3. Bradley K.N., Rowan E.G., Harvey A.L. Effects of muscarinic toxins MT2 and MT7, from green mamba venom, on m1, m3 and m5 muscarinic receptors expressed in Chinese Hamster Ovary cells. Toxicon 2003, 41:207-215.
4. Carsi J.M., Valentine H.H., Potter L.T. m2-toxin: a selective ligand for M2 muscarinic receptors. Mol. Pharmacol. 1999, 56:933-937.
5. Caulfield M.P., Birdsall N.J. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev. 1998, 50:279-290.
6. Chen Z., Rogge G., Hague C., Alewood D., Colless B., Lewis R.J., Minneman K.P. Subtype-selective noncompetitive or competitive inhibition of human alpha1-adrenergic receptors by rho-TIA. J. Biol. Chem. 2004, 279:35326-35333.
7. Chung C., Wu B.N., Yang C.C., Chang L.S. Muscarinic toxin-like proteins from Taiwan banded krait (Bungarus multicinctus) venom: purification, characterization and gene organization. Biol. Chem. 2002, 383:1397-1406.
8. Craig A.G., Norberg T., Griffin D., Hoeger C., Akhtar M., Schmidt K., Low W., Dykert J., Richelson E., Navarro V., Mazella J., Watkins M., Hillyard D., Imperial J., Cruz L.J., Olivera B.M. Contulakin-G, an O-glycosylated invertebrate neurotensin. J. Biol. Chem. 1999, 274:13752-13759.
9. Doley R., Mackessy S.P., Kini R.M. Role of accelerated segment switch in exons to alter targeting (ASSET) in the molecular evolution of snake venom proteins. BMC Evol. Biol. 2009, 9:146.
10. Ducancel F. The sarafotoxins. Toxicon 2002, 40:1541-1545.
11. Ducancel F. Endothelin-like peptides. Cell. Mol. Life Sci. 2005, 62:2828-2839.
12. Ducancel F., Rowan E.G., Cassar E., Harvey A.L., Menez A., Boulain J.C. Amino acid sequence of a muscarinic toxin deduced from the cDNA nucleotide sequence. Toxicon 1991, 29:516-520.
13. Fruchart-Gaillard C., Mourier G., Marquer C., Menez A., Servent D. Identification of various allosteric interaction sites on M1 muscarinic receptor using 125I-Met35-oxidized muscarinic toxin 7. Mol. Pharmacol. 2006, 69:1641-1651.
14. Fruchart-Gaillard C., Mourier G., Marquer C., Stura E., Birdsall N.J., Servent D. Different interactions between MT7 toxin and the human muscarinic M1 receptor in its free and NMS-occupied states. Mol. Pharmacol. 2008, 74:1554-1563.
15. Fry B.G., Wuster W., Kini R.M., Brusic V., Khan A., Venkataraman D., Rooney A.P. Molecular evolution and phylogeny of elapid snake venom three-finger toxins. J. Mol. Evol. 2003, 57:110-129.
16. Galat A., Gross G., Drevet P., Sato A., Menez A. Conserved structural determinants in three-fingered protein domains. Febs J. 2008, 275:3207-3225.
17. Goin J.C., Nathanson N.M. Quantitative analysis of muscarinic acetylcholine receptor homo- and heterodimerization in live cells: regulation of receptor down-regulation by heterodimerization. J. Biol. Chem. 2006, 281:5416-5425.
18. Harvey A.L., Kornisiuk E., Bradley K.N., Cervenansky C., Duran R., Adrover M., Sanchez G., Jerusalinsky D. Effects of muscarinic toxins MT1 and MT2 from green mamba on different muscarinic cholinoceptors. Neurochem. Res. 2002, 27:1543-1554.
19. Hogan K., Markos F. Muscarinic type 1 receptors mediate part of nitric oxide's vagal facilitatory effect in the isolated innervated rat right atrium. Nitric Oxide 2007, 16:110-117.
20. Huang L.F., Zheng J.B., Xu Y., Song H.T., Yu C.X. A snake venom phospholipase A2 with high affinity for muscarinic acetylcholine receptors acts on guinea pig ileum. Toxicon 2008, 51:1008-1016.
21. Jerusalinsky D., Cervenansky C., Walz R., Bianchin M., Izquierdo I. A peptide muscarinic toxin from the Green Mamba venom shows agonist-like action in an inhibitory avoidance learning task. Eur. J. Pharmacol. 1993, 240:103-105.
22. Jerusalinsky D., Cervenasky C., Pena C., Raskovsky S., Dajas F. Two polypeptides from Dendroaspis angusticeps venom selectively inhibit the binding of central muscarinic cholinergic receptor ligands. Neurochem. Int. 1992, 20:237-246.
23. Jerusalinsky D., Harvey A.L. Toxins from mamba venoms: small proteins with selectivities for different subtypes of muscarinic acetylcholine receptors. Trends Pharmacol. Sci. 1994, 15:424-430.
24. Jerusalinsky D., Kornisiuk E., Alfaro P., Quillfeldt J., Alonso M., Verde E.R., Cervenansky C., Harvey A. Muscarinic toxin selective for m4 receptors impairs memory in the rat. Neuroreport 1998, 9:1407-1411.
25. Jerusalinsky D., Kornisiuk E., Alfaro P., Quillfeldt J., Ferreira A., Rial V.E., Duran R., Cervenansky C. Muscarinic toxins: novel pharmacological tools for the muscarinic cholinergic system. Toxicon 2000, 38:747-761.
26. Jerusalinsky D., Kornisiuk E., Cervenansky C., Harvey A. Allosteric activation of M1 muscarinic cholinoceptors by MTx1, a protein from green mamba snake venom. Life Sci. 1995, 56:1015.
27. Jolkkonen, M., 1996. Muscarinic toxins from Dendroaspis (mamba) venom: peptides selective for subtypes of muscarinic acetylcholine receptors. Comprehensive Summaries of Uppsala dissertations from the Faculty of Science and Technology 183.
28. Jolkkonen M., Adem A., Hellman U., Wernstedt C., Karlsson E. A snake toxin against muscarinic acetylcholine receptors: amino acid sequence, subtype specificity and effect on guinea-pig ileum. Toxicon 1995, 33:399-410.
29. Jolkkonen M., Oras A., Toomela T., Karlsson E., Jarv J., Akerman K.E. Kinetic evidence for different mechanisms of interaction of black mamba toxins MT alpha and MT beta with muscarinic receptors. Toxicon 2001, 39:377-382.
30. Jolkkonen M., van Giersbergen P.L., Hellman U., Wernstedt C., Karlsson E. A toxin from the green mamba Dendroaspis angusticeps: amino acid sequence and selectivity for muscarinic m4 receptors. FEBS Lett. 1994, 352:91-94.
31. Jolkkonen M., Van Giersbergen P.L., Hellman U., Wernstedt C., Oras A., Satyapan N., Adem A., Karlsson E. Muscarinic toxins from the black mamba Dendroaspis polylepis. Eur. J. Biochem. 1995, 234:579-585.
32. Joubert F.J. The amino acid sequence of protein CM-3 from Dendroaspis polylepis polylepis (black mamba) venom. Int. J. Biochem. 1985, 17:695-699.
33. Kang Y.J., Eisenach J.C. Intrathecal clonidine reduces hypersensitivity after nerve injury by a mechanism involving spinal m4 muscarinic receptors. Anesth. Analg 2003, 96:1403-1408.
34. Karlsson E., Jolkkonen M., Satyapan N., Adem A., Kumlin E., Hellman U., Wernstedt C. Protein toxins that bind to muscarinic acetylcholine receptors. Ann. N. Y. Acad. Sci. 1994, 710:153-161.
35. Karlsson E., Jolkonen M., Mulugeta E., Onali P., Adem A. Snake toxins with high selectivity for subtypes of muscarinic acetylcholine receptors. Biochimie 2000, 82:793-806.
36. Kaser A., Winklmayr M., Lepperdinger G., Kreil G. The AVIT protein family. Secreted cysteine-rich vertebrate proteins with diverse functions. EMBO Rep. 2003, 4:469-473.
37. Kini R.M., Doley R. Structure, function and evolution of three-finger toxins: mini proteins with multiple targets. Toxicon 2010, 56:855-867.
38. Koivula K., Rondinelli S., Nasman J. The three-finger toxin MTalpha is a selective alpha(2B)-adrenoceptor antagonist. Toxicon 2010, 56:440-447.
39. Kornisiuk E., Jerusalinsky D., Cervenansky C., Harvey A.L. Binding of muscarinic toxins MTx1 and MTx2 from the venom of the green mamba Dendroaspis angusticeps to cloned human muscarinic cholinoceptors. Toxicon 1995, 33:11-18.
40. Krajewski J.L., Dickerson I.M., Potter L.T. Site-directed mutagenesis of m1-toxin1: two amino acids responsible for stable toxin binding to M(1) muscarinic receptors. Mol. Pharmacol. 2001, 60:725-731.
41. Kukhtina V.V., Weise C., Muranova T.A., Starkov V.G., Franke P., Hucho F., Wnendt S., Gillen C., Tsetlin V.I., Utkin Y.N. Muscarinic toxin-like proteins from cobra venom. Eur. J. Biochem. 2000, 267:6784-6789.
42. Kukkonen A., Perakyla M., Akerman K.E., Nasman J. Muscarinic toxin 7 selectivity is dictated by extracellular receptor loops. J. Biol. Chem. 2004, 279:50923-50929.
43. Langmead C.J., Watson J., Reavill C. Muscarinic acetylcholine receptors as CNS drug targets. Pharmacol. Ther. 2008, 117:232-243.
44. Liang J., Gutierrez-Ford C., Potter L.T. Sustained unilateral blockade of rat striatal M(1) muscarinic receptors with m1-toxin1 in vivo. Brain Res. 2001, 921:211-218.
45. Liang J.S., Carsi-Gabrenas J., Krajewski J.L., McCafferty J.M., Purkerson S.L., Santiago M.P., Strauss W.L., Valentine H.H., Potter L.T. Anti-muscarinic toxins from Dendroaspis angusticeps. Toxicon 1996, 34:1257-1267.
46. Marino M.J., Rouse S.T., Levey A.I., Potter L.T., Conn P.J. Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells. Proc. Natl. Acad. Sci. U S A 1998, 95:11465-11470.
47. Marquer, C., Fruchart-Gaillard, C., Letellier, G., Marcon, E., Mourier, G., Zinn-Justin, S., Menez, A., Servent, D., Gilquin, B. A structural model of a ligand/GPCR complex based on experimental double-mutant cycle data: the MT7 snake toxin bound to a dimeric hM1 muscarinic receptor. J. Biol. Chem., in press. First Published on June 17, 2011, doi:10.1074/jbc.M111.261404.
48. Marquer C., Fruchart-Gaillard C., Mourier G., Grandjean O., Girard E., le Maire M., Brown S., Servent D. Influence of MT7 toxin on the oligomerization state of the M1 muscarinic receptor. Biol. Cell 2010, 102:409-420.
49. Max S.I., Liang J.S., Potter L.T. Purification and properties of m1-toxin, a specific antagonist of m1 muscarinic receptors. J. Neurosci. 1993, 13:4293-4300.
50. Max S.I., Liang J.S., Potter L.T. Stable allosteric binding of m1-toxin to m1 muscarinic receptors. Mol. Pharmacol. 1993, 44:1171-1175.
51. Max S.I., Liang J.S., Valentine H.H., Potter L.T. Use of m1-toxin as a selective antagonist of m1 muscarinic receptors. J. Pharmacol. Exp. Ther. 1993, 267:480-485.
52. Ménez R., Ducruix A. A toxin that recognizes muscarinic acetylcholine receptors. Preparation and characterization of crystals suitable for structural analysis. J. Mol. Biol. 1993, 232:997-998.
53. Michel M.C., Oelke M., Zinner N. Novel muscarinic antagonist to treat incontinence and/or overactive bladder. Drug Discovery Today:Therapeutic Strateg. 2005, 2:1-6.
54. Minic J., Molgo J., Karlsson E., Krejci E. Regulation of acetylcholine release by muscarinic receptors at the mouse neuromuscular junction depends on the activity of acetylcholinesterase. Eur. J. Neurosci. 2002, 15:439-448.
55. Miyoshi S., Tu A.T. Phospholipase A2 from Naja naja sputatrix venom is a muscarinic acetylcholine receptor inhibitor. Arch. Biochem. Biophys. 1996, 328:17-25.
56. Miyoshi S., Tu A.T. Muscarinic acetylcholine receptor (mAChR) inhibitor from snake venom: interaction with subtypes of human mAChR. Arch. Biochem. Biophys. 1999, 369:114-118.
57. Miyoshi S., Tu A.T. A snake venom inhibitor to muscarinic acetylcholine receptor (mAChR): isolation and interaction with cloned human mAChR. Arch. Biochem. Biophys. 2000, 377:290-295.
58. Morais K.L., Hayashi M.A., Bruni F.M., Lopes-Ferreira M., Camargo A.C., Ulrich H., Lameu C. Bj-PRO-5a, a natural angiotensin-converting enzyme inhibitor, promotes vasodilatation mediated by both bradykinin B(2) and M1 muscarinic acetylcholine receptors. Biochem. Pharmacol. 2010, 81:736-742.
59. Mordvintsev D.Y., Polyak Y.L., Rodionov D.I., Jakubik J., Dolezal V., Karlsson E., Tsetlin V.I., Utkin Y.N. Weak toxin WTX from Naja kaouthia cobra venom interacts with both nicotinic and muscarinic acetylcholine receptors. Febs J. 2009, 276:5065-5075.
60. Mourier G., Dutertre S., Fruchart-Gaillard C., Ménez A., Servent D. Chemical synthesis of MT1 and MT7 muscarinic toxins: critical role of Arg-34 in their interaction with M1 muscarinic receptor. Mol. Pharmacol. 2003, 63:26-35.
61. Mulugeta E., Karlsson E., Islam A., Kalaria R., Mangat H., Winblad B., Adem A. Loss of muscarinic M4 receptors in hippocampus of Alzheimer patients. Brain Res. 2003, 960:259-262.
62. Nareoja K., Kukkonen J., Rondinelli S., Toivola D., Meriluoto J., Nasman J. Adrenoceptor activity of muscarinic toxins identified from mamba venoms. Br. J. Pharmacol 2011, 164:538-560.
63. Nasman J., Jolkkonen M., Ammoun S., Karlsson E., Akerman K.E. Recombinant expression of a selective blocker of M(1) muscarinic receptors. Biochem. Biophys. Res. Commun. 2000, 271:435-439.
64. Negraes P.D., Lameu C., Hayashi M.A., Melo R.L., Camargo A.C., Ulrich H. The snake venom peptide Bj-PRO-7a is a M1 muscarinic acetylcholine receptor agonist. Cytometry A 2011, 79:77-83.
65. Nielsen D.B., Dykert J., Rivier J.E., McIntosh J.M. Isolation of Lys-conopressin-G from the venom of the worm-hunting snail, Conus imperialis. Toxicon 1994, 32:845-848.
66. Nirthanan S., Gwee M.C. Three-finger alpha-neurotoxins and the nicotinic acetylcholine receptor, forty years on. J. Pharmacol. Sci. 2004, 94:1-17.
67. Olianas M.C., Adem A., Karlsson E., Onali P. Rat striatal muscarinic receptors coupled to the inhibition of adenylyl cyclase activity: potent block by the selective m4 ligand muscarinic toxin 3 (MT3). Br. J. Pharmacol. 1996, 118:283-288.
68. Olianas M.C., Adem A., Karlsson E., Onali P. Action of the muscarinic toxin MT7 on agonist-bound muscarinic M1 receptors. Eur. J. Pharmacol. 2004, 487:65-72.
69. Olianas M.C., Maullu C., Adem A., Mulugeta E., Karlsson E., Onali P. Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7). Br. J. Pharmacol. 2000, 131:447-452.
70. Osman O.H., Ismail M., el-Asmar M.F. Pharmacological studies of snake (Dendroaspis angusticeps) venom. Toxicon 1973, 11:185-192.
71. Purkerson S.L., Potter L.T. Use of antimuscarinic toxins to facilitate studies of striatal m4 muscarinic receptors. J. Pharmacol. Exp. Ther. 1998, 284:707-713.
72. Quinton L., Girard E., Maiga A., Rekik M., Lluel P., Masuyer G., Larregola M., Marquer C., Ciolek J., Magnin T., Wagner R., Molgo J., Thai R., Fruchart-Gaillard C., Mourier G., Chamot-Rooke J., Menez A., Palea S., Servent D., Gilles N. Isolation and pharmacological characterization of AdTx1, a natural peptide displaying specific insurmountable antagonism of the alpha(1A)-adrenoceptor. Br. J. Pharmacol. 2010, 159:316-325.
73. Rajagopalan N., Pung Y.F., Zhu Y.Z., Wong P.T., Kumar P.P., Kini R.M. Beta-cardiotoxin: a new three-finger toxin from Ophiophagus hannah (king cobra) venom with beta-blocker activity. Faseb J. 2007, 21:3685-3695.
74. Rouget C., Quinton L., Maiga A., Gales C., Masuyer G., Malosse C., Chamot-Rooke J., Thai R., Mourier G., dePauw E., Gilles N., Servent D. Specific inhibition of the alpha2-adrenoceptors by a natural antagonist peptide toxin. Br. J. Pharmacol. 2010, 161:1361-1374.
75. Sanchez G., Alvares Lde O., Oberholzer M.V., Genro B., Quillfeldt J., da Costa J.C., Cervenansky C., Jerusalinsky D., Kornisiuk E. M4 muscarinic receptors are involved in modulation of neurotransmission at synapses of Schaffer collaterals on CA1 hippocampal neurons in rats. J. Neurosci. Res. 2009, 87:691-700.
76. Sanchez G., Colettis N., Vazquez P., Cervenansky C., Aguirre A., Quillfeldt J.A., Jerusalinsky D., Kornisiuk E. Muscarinic inhibition of hippocampal and striatal adenylyl cyclase is mainly due to the M(4) receptor. Neurochem. Res. 2009, 34:1363-1371.
77. Santiago M.P., Potter L.T. Biotinylated m4-toxin demonstrates more M4 muscarinic receptor protein on direct than indirect striatal projection neurons. Brain Res. 2001, 894:12-20.
78. Ségalas I., Roumestand C., Zinn-Justin S., Gilquin B., Ménez R., Ménez A., Toma F. Solution structure of a green mamba toxin that activates muscarinic acetylcholine receptors, as studied by nuclear magnetic resonance and molecular modeling. Biochemistry 1995, 34:1248-1260.
79. Servent D., Fruchart-Gaillard C. Muscarinic toxins: tools for the study of the pharmacological and functional properties of muscarinic receptors. J. Neurochem. 2009, 109:1193-1202.
80. Servent D., Ménez A. Snake neurotoxins that interact with nicotinic acetylcholine receptors. Handbook of Neurotoxicology 2001, 385-425. Humana Press Inc., Totowa, NJ. E.J. Massaro (Ed.).
81. Sharpe I.A., Gehrmann J., Loughnan M.L., Thomas L., Adams D.A., Atkins A., Palant E., Craik D.J., Adams D.J., Alewood P.F., Lewis R.J. Two new classes of conopeptides inhibit the alpha1-adrenoceptor and noradrenaline transporter. Nat. Neurosci. 2001, 4:902-907.
82. Tsetlin V. Snake venom alpha-neurotoxins and other 'three-finger' proteins. Eur. J. Biochem. 1999, 264:281-286.
83. Waelbroeck M., De Neef P., Domenach V., Vandermeers-Piret M.C., Vandermeers A. Binding of the labelled muscarinic toxin 125I-MT1 to rat brain muscarinic M1 receptors. Eur. J. Pharmacol. 1996, 305:187-192.
84. Wang J.Q., Jolkkonen M., McGinty J.F. The muscarinic toxin 3 augments neuropeptide mRNA in rat striatum in vivo. Eur. J. Pharmacol. 1997, 334:43-47.
85. Wess J., Eglen R.M., Gautam D. Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat. Rev. Drug Discov. 2007, 6:721-733.
86. Wirtshafter D. The selective m1 muscarinic antagonist MT-7 blocks pilocarpine-induced striatal Fos expression. Brain Res. 2006, 1085:127-131.
87. Zeng F.Y., Hopp A., Soldner A., Wess J. Use of a disulfide cross-linking strategy to study muscarinic receptor structure and mechanisms of activation. J. Biol. Chem. 1999, 274:16629-16640.